IGEA Medical UK

At IGEA we study the clinical application of physical stimuli to biological systems.  

IGEA is the leading company for Electrochemotherapy, a minimally invasive treatment combining a low dose of a chemotherapy drug and an electrical pulse (electroporation) applied directly to the cancer cells using specific multiple, or individual needle electrodes.  

Our mission is to improve patients’ Quality of Life by developing and producing innovative, effective and safe therapeutic systems for clinical practice.